Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Lung Cancer

Free Subscription 27.10.2025 1 Am J Respir Crit Care Med 2 Ann Oncol 2 Ann Surg Oncol 1 Ann Thorac Surg 1 Arch Bronconeumol 4 BMC Cancer 1 Cancer 1 Cancer Res 2 Clin Lung Cancer 1 Int J Radiat Oncol Biol Phys 1 J Clin Oncol 1 Lancet 4 Lung Cancer 1 Oncologist 4 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Respir Crit Care Med

1. OSTRIN E
   Fragments of a Story: Could Mitochondrial DNA Fragmentomics Upend Lung Cancer Early Diagnosis?
   Am J Respir Crit Care Med. 2025 Oct 22. doi: 10.1164/rccm.202508-1874.
   PubMed        
   
   

   
   Ann Oncol

2. KOSTER KL, Fruh M
   Long-Term Survival in the ALEX Trial: A Milestone in Improving the Prognosis of Patients with ALK-Positive Non-Small Cell Lung Cancer.
   Ann Oncol. 2025 Oct 17:S0923-7534(25)04933-6. doi: 10.1016/j.annonc.2025.
   PubMed        
   
   
3. PETERS S, Camidge R, Dziadziuszko R, Gadgeel S, et al
   Alectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: final overall survival analysis of the phase III ALEX study.
   Ann Oncol. 2025 Oct 17:S0923-7534(25)04788-X. doi: 10.1016/j.annonc.2025.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

4. YAN H, Niimi T, Matsunaga T, Fukui M, et al
   Personalized Surgical Decision-Making Model for Clinical Stage IA Pure-Solid Non-small Cell Lung Cancer.
   Ann Surg Oncol. 2025 Oct 21. doi: 10.1245/s10434-025-18610.
   PubMed         Abstract available
   
   
5. WU S, Chen X, Bo E, Diao H, et al
   ASO Author Reflections: The Survival for Pneumonectomy After Neoadjuvant Therapy in Non-Small Cell Lung Cancer.
   Ann Surg Oncol. 2025 Oct 17. doi: 10.1245/s10434-025-18576.
   PubMed        
   
   

   
   Ann Thorac Surg

6. MOONSAMY P
   Improving Lung Cancer Screening Rates is the Most Important Problem Facing Thoracic Surgeons Today.
   Ann Thorac Surg. 2025 Oct 17:S0003-4975(25)00987.
   PubMed        
   
   

   
   Arch Bronconeumol

7. ALONSO ROBLES AM, Vivancos Gallego MJ, Gorospe Sarasua L
   Incidental Finding of a Solitary Sternal Plasmacytoma Detected at Lung Cancer Screening With Low-dose CT in a Smoker With HIV Infection.
   Arch Bronconeumol. 2025 Oct 4:S0300-2896(25)00349.
   PubMed        
   
   

   
   BMC Cancer

8. LI H, Li P, Zhu S, Hou W, et al
   Different detection rates of brain metastasis in different pathological types of lung cancer by (18)F-FAPI PET/CT.
   BMC Cancer. 2025;25:1620.
   PubMed         Abstract available
   
   
9. SHIN JE, Park S, Jung HA, Sun JM, et al
   Combination of chemotherapy and immune checkpoint inhibitors in non-small cell lung cancer with actionable gene alterations other than EGFR, ALK, and ROS1 mutations: a retrospective observational study.
   BMC Cancer. 2025;25:1616.
   PubMed         Abstract available
   
   
10. MOKHTARI V, Hashemi M, Marandi SJ, Jebali A, et al
    Design, synthesis, and evaluation of A therapeutic vaccine candidate against lung cancer based on multi-epitopes of MAGE-A3, TGF-beta2, and VEGF-A.
    BMC Cancer. 2025;25:1632.
    PubMed        
    
    
11. ZHANG Y, Zhang Q, Wang L, Hu Y, et al
    The value of second-generation gene sequencing in lung cancer immunotherapy with concurrent infections.
    BMC Cancer. 2025;25:1636.
    PubMed        
    
    

    
    Cancer

12. MAMDANI H, Gentzler RD, Gu L, Chiappori AA, et al
    A Phase II study of GT103 in combination with pembrolizumab in refractory, metastatic non-small cell lung cancer.
    Cancer. 2025;131:e70141.
    PubMed         Abstract available
    
    

    
    Cancer Res

13. ZHANG S, Wang S, Wang Y, Zhou T, et al
    PRMT3 Drives IDO1-Dependent Radioresistance and Immunosuppression by Promoting Kynurenine Metabolism in Non-Small Cell Lung Cancer.
    Cancer Res. 2025 Oct 23. doi: 10.1158/0008-5472.CAN-24-4162.
    PubMed         Abstract available
    
    

    
    Clin Lung Cancer

14. ALVAREZ AAR, Sun Y, Li Y, Christiani DC, et al
    Effects of Sex on Mortality in Patients With Lung Cancer: A Multiple Mediation Analysis of The Boston Lung Cancer Study.
    Clin Lung Cancer. 2025 Sep 24:S1525-7304(25)00233.
    PubMed         Abstract available
    
    
15. NAKAMURA M, Kageyama SI, Hirata H, Ohira M, et al
    Tumor-Agnostic Circulating Tumor DNA Analysis as a Comprehensive Predictive Biomarker of Recurrence after Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2025 Oct 1:S1525-7304(25)00238.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

16. CHEN X, Zhang X, Xu T, Mohan R, et al
    Radiation doses to cardiac substructures predict elevation in high-sensitivity cardiac troponin T (hs-cTnT) levels in radiotherapy for lung cancer.
    Int J Radiat Oncol Biol Phys. 2025 Oct 17:S0360-3016(25)06388.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

17. JOHNSON ML, Smit EF, Felip E, Ramalingam SS, et al
    Updated Overall Survival Analysis From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer.
    J Clin Oncol. 2025 Oct 19:101200JCO2502023. doi: 10.1200/JCO-25-02023.
    PubMed         Abstract available
    
    

    
    Lancet

18. CHEN Z, Yang F, Jiang Z, Sun L, et al
    Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial.
    Lancet. 2025 Oct 19:S0140-6736(25)01848-3. doi: 10.1016/S0140-6736(25)01848.
    PubMed         Abstract available
    
    

    
    Lung Cancer

19. ABELE M, Karelin A, Pogoda M, Faust U, et al
    Distinct genomic profile of pediatric lung carcinoma: High frequency of ALK fusions and TP53 mutations compared to adults.
    Lung Cancer. 2025;209:108800.
    PubMed         Abstract available
    
    
20. BRANDAO M, Prisciandaro E, Xenophontos E, Mariolo A, et al
    Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group.
    Lung Cancer. 2025;209:108798.
    PubMed         Abstract available
    
    
21. TAKADA K, Shimokawa M, Cortellini A, Pinato DJ, et al
    Probiotic supplement exposure and outcomes of patients with non-small cell lung cancer treated with first-line atezolizumab therapy: Pooled analysis of individual patient data from five randomized control trials.
    Lung Cancer. 2025;209:108787.
    PubMed         Abstract available
    
    
22. VEERASATIAN T, Rattanapitoon SK, Thanchonnang C, Rattanapitoon NK, et al
    Reframing BALF liquid biopsy: Defining the BALF-plasma continuum for molecular diagnosis and early lung cancer management.
    Lung Cancer. 2025;209:108794.
    PubMed        
    
    

    
    Oncologist

23. WANG Z, Ding P, Zhou H, Kuang B, et al
    Intrathecal pemetrexed for leptomeningeal metastasis from lung adenocarcinoma: a clinical efficacy and multiplex liquid proteomics exploration study.
    Oncologist. 2025;30:oyaf291.
    PubMed         Abstract available
    
    

    
    PLoS One

24. ESTIFANOS N, Egata G, Addissie A, Argaw Kebede R, et al
    Lung cancer symptoms awareness among Ethiopian adults: A latent class analysis.
    PLoS One. 2025;20:e0332952.
    PubMed         Abstract available
    
    
25. 
    Retraction: Ginkgo biloba Extract Decreases Non-Small Cell Lung Cancer Cell Migration by Downregulating Metastasis-Associated Factor Heat-Shock Protein 27.
    PLoS One. 2025;20:e0335087.
    PubMed        
    
    
26. SHAO K, Chai C, Yang Y, Chen W, et al
    Dosimetric comparison of Monte Carlo, Acuros XB, and anisotropic analytical algorithm for lung cancer plans on halcyon accelerators.
    PLoS One. 2025;20:e0334329.
    PubMed         Abstract available
    
    
27. NAGASE W, Harada K, Kudo Y, Matsubayashi J, et al
    AI-driven 3D CT imaging prediction model for improving preoperative detection of visceral pleural invasion in early-stage lung cancer.
    PLoS One. 2025;20:e0332956.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

28. SCHULTZ CW, Saha S, Dhall A, Zhang Y, et al
    Lamin A/C loss promotes R-loop-mediated genomic instability and poor survival in small-cell lung cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2503387122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.